Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify transcriptomic immune response biomarker signatures induc...
Main Authors: | Vianello, E, Gonzalez-Dias, P, van Veen, S, Engele, CG, Quinten, E, Monath, TP, Medaglini, D, Agnandij, ST, Ahmed, R, Anderson, J, Auderset, F, Bejon, P, Borgianni, L, Brosnahan, J, Ciabattini, A, Engler, O, Haks, MC, Harandi, AM, Heppner, DG, Gerlini, A, Huttner, A, Kremsner, PG, Ndungu, FM, Njuguna, P, Ottenhoff, THM, Pejoski, D, Page, M, Pozzi, G, Santoro, F, Siegrist, CA, Dubey, S, Eichberg, M, Ndong, EP, Lumeka, K, Nakaya, HI, Gonzales Dias Carvalho, P, Rothenberger, S, Nakka, SS, Essone, PN, Agnandji, ST |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2021
|
Registos relacionados
-
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP
Por: Eleonora Vianello, et al.
Publicado em: (2023-12-01) -
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
Por: Eleonora Vianello, PhD, et al.
Publicado em: (2022-02-01) -
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
Por: Huttner, A, et al.
Publicado em: (2018) -
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination
Por: Pejoski, D, et al.
Publicado em: (2020) -
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.
Por: Selidji T Agnandji, et al.
Publicado em: (2017-10-01)